Inhaled short-acting beta2-agonists versus ipratropium for acute exacerbations of chronic obstructive pulmonary disease.
about
An integrative review of systematic reviews related to the management of breathlessness in respiratory illnessesMeta-analysis: anticholinergics, but not beta-agonists, reduce severe exacerbations and respiratory mortality in COPD.Bronchodilators in COPD: impact of beta-agonists and anticholinergics on severe exacerbations and mortality.
P2860
Inhaled short-acting beta2-agonists versus ipratropium for acute exacerbations of chronic obstructive pulmonary disease.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Inhaled short-acting beta2-ago ...... obstructive pulmonary disease.
@ast
Inhaled short-acting beta2-ago ...... obstructive pulmonary disease.
@en
Inhaled short-acting beta2-ago ...... obstructive pulmonary disease.
@nl
type
label
Inhaled short-acting beta2-ago ...... obstructive pulmonary disease.
@ast
Inhaled short-acting beta2-ago ...... obstructive pulmonary disease.
@en
Inhaled short-acting beta2-ago ...... obstructive pulmonary disease.
@nl
prefLabel
Inhaled short-acting beta2-ago ...... obstructive pulmonary disease.
@ast
Inhaled short-acting beta2-ago ...... obstructive pulmonary disease.
@en
Inhaled short-acting beta2-ago ...... obstructive pulmonary disease.
@nl
P2860
P1476
Inhaled short-acting beta2-ago ...... obstructive pulmonary disease.
@en
P2093
D C McCrory
P2860
P304
P356
10.1002/14651858.CD002984
P577
2001-01-01T00:00:00Z